3- (1, 3-benzodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) - pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist

Details for Australian Patent Application No. 2011236055 (hide)

Owner High Point Pharmaceuticals, LLC

Inventors Hohlweg, Rolf

Agent Shelston IP

Pub. Number AU-A-2011236055

Parent 2007267197

Filing date 14 October 2011

Wipo publication date 3 November 2011

International Classifications

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

3 November 2011 Application Open to Public Inspection

  Published as AU-A-2011236055

3 November 2011 Complete Application Filed

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011236056-Nucleic acid sequences encoding proteins capable of associating into a virus-like particle

2011236054-Composite plate and method of forming the same